CME Group Inc (CME) Sets 52-Week High; Strong Momentum for Holders

September 17, 2017 - By test

Investors sentiment decreased to 1.1 in 2016 Q4. Its down 0.27, from 1.37 in 2016Q3. It is negative, as 39 investors sold CME Group Inc shares while 231 reduced holdings. 81 funds opened positions while 215 raised stakes. 273.92 million shares or 3.61% more from 264.37 million shares in 2016Q3 were reported.
Guinness Atkinson Asset Mngmt Inc holds 0.15% or 1,900 shares in its portfolio. Gotham Asset Mgmt Limited Liability has 7,218 shares for 0.01% of their portfolio. Hsbc Holding Public Limited Company invested 0.19% in CME Group Inc (NASDAQ:CME). Pitcairn Co holds 0.05% or 3,233 shares in its portfolio. 2,600 are held by Yorktown Management & Research Commerce. New York-based Bluefin Trading Llc has invested 0.06% in CME Group Inc (NASDAQ:CME). Comerica Bank & Trust holds 0.08% in CME Group Inc (NASDAQ:CME) or 85,203 shares. Johnson Financial reported 899 shares. Beacon Trust holds 48,114 shares or 0.91% of its portfolio. Moreover, Magnetar Fincl Ltd Llc has 0.02% invested in CME Group Inc (NASDAQ:CME) for 14,710 shares. Hudson Bay Mgmt L P owns 0.01% invested in CME Group Inc (NASDAQ:CME) for 5,900 shares. 351 were reported by Carroll Associate. Horizon Invests Limited Liability owns 6,494 shares. Tarbox holds 0.01% or 97 shares. Glg Prtn Lp, a United Kingdom-based fund reported 17,000 shares.

Since April 10, 2017, it had 0 insider buys, and 8 sales for $3.85 million activity. Shares for $248,298 were sold by Sammann Derek on Wednesday, June 7. Winkler Julie sold $539,148 worth of stock or 4,315 shares. Holzrichter Julie had sold 5,925 shares worth $700,502 on Wednesday, June 7. 4,125 shares were sold by Kometer Kevin, worth $505,081 on Friday, June 9. $294,625 worth of CME Group Inc (NASDAQ:CME) was sold by Pietrowicz John W.. Shares for $1.21 million were sold by Cutinho Sunil.

The stock of CME Group Inc (NASDAQ:CME) hit a new 52-week high and has $137.89 target or 5.00 % above today’s $131.32 share price. The 7 months bullish chart indicates low risk for the $44.64 billion company. The 1-year high was reported on Sep, 17 by Barchart.com. If the $137.89 price target is reached, the company will be worth $2.23B more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.61% or $0.8 on September 15, reaching $131.32. About 1.67M shares traded or 49.11% up from the average. CME Group Inc (NASDAQ:CME) has risen 25.35% since September 17, 2016 and is uptrending. It has outperformed by 8.65% the S&P500.

Analysts await CME Group Inc (NASDAQ:CME) to report earnings on October, 26. They expect $1.18 EPS, up 12.38 % or $0.13 from last year’s $1.05 per share. CME’s profit will be $401.12 million for 27.82 P/E if the $1.18 EPS becomes a reality. After $1.23 actual EPS reported by CME Group Inc for the previous quarter, Wall Street now forecasts -4.07 % negative EPS growth.

CME Group Inc (NASDAQ:CME) Ratings Coverage

Among 14 analysts covering CME Group (NASDAQ:CME), 8 have Buy rating, 1 Sell and 5 Hold. Therefore 57% are positive. CME Group has $139 highest and $2.78 lowest target. $99.82’s average target is -23.99% below currents $131.32 stock price. CME Group had 42 analyst reports since August 3, 2015 according to SRatingsIntel. Deutsche Bank maintained it with “Buy” rating and $105 target in Tuesday, January 26 report. The company was maintained on Tuesday, August 1 by RBC Capital Markets. UBS maintained the shares of CME in report on Friday, July 29 with “Buy” rating. Deutsche Bank maintained the stock with “Buy” rating in Wednesday, October 5 report. The stock of CME Group Inc (NASDAQ:CME) has “Equal Weight” rating given on Tuesday, August 11 by Barclays Capital. CLSA maintained CME Group Inc (NASDAQ:CME) on Thursday, July 14 with “Underperform” rating. The firm has “Buy” rating given on Friday, July 29 by Deutsche Bank. The stock has “Buy” rating by RBC Capital Markets on Monday, September 11. The stock of CME Group Inc (NASDAQ:CME) has “Neutral” rating given on Friday, September 4 by JP Morgan. The firm has “Neutral” rating by JP Morgan given on Friday, March 11.

More notable recent CME Group Inc (NASDAQ:CME) news were published by: Nasdaq.com which released: “CME Group Inc. (CME) Ex-Dividend Date Scheduled for September 07, 2017” on September 06, 2017, also Reuters.com with their article: “CME Group to exit OTC credit default swap clearing business” published on September 14, 2017, Nasdaq.com published: “CME Group Makes Clean Sweep With Solid Average Daily Volume” on September 07, 2017. More interesting news about CME Group Inc (NASDAQ:CME) were released by: Seekingalpha.com and their article: “CME Group (CME) Presents at Barclays Financial Services Conference (Transcript)” published on September 12, 2017 as well as Finance.Yahoo.com‘s news article titled: “Why Should You Retain CME Group (CME) in Your Portfolio” with publication date: August 18, 2017.

CME Group Inc., through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company has market cap of $44.64 billion. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc. , Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX) exchanges. It has a 26.84 P/E ratio. The Firm provides electronic trading around the globe on its CME Globex platform.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: